跳至主要内容
临床试验/NCT03898466
NCT03898466已完成4 期

The Effect of Once-daily Fluticasone Furoate on Methacholine-induced Bronchoconstriction in Mild Asthmatics

University of Saskatchewan1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2018年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Methacholine provocation dose causing a 20% fall in FEV1 (PD20)

研究概览

简要总结

The study will determine the effect of inhaled fluticasone furoate on airway responsiveness to methacholine in mild asthmatics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • forced expiratory volume in one second (FEV1) greater than or equal to 65% predicted
  • methacholine PD20 less than or equal to 400mcg
  • no allergen exposure (if atopic) or respiratory infection for at least 4 weeks prior to study start

排除标准

  • regular use of inhaled corticosteroid within 4 weeks of study start
  • poorly controlled asthma
  • current smoker or ex smoker with greater than 10 pack year history
  • pregnancy or breast-feeding
  • health concern/condition that would preclude participation for safety reasons

研究组 & 干预措施

Fluticasone Furoate

Experimental

Daily inhalation of 100mcg fluticasone furoate for 7 days Response to methacholine induced bronchoconstriction will be assessed on Day 1 before first inhalation of study treatment (baseline) and again at 24, 72 and 168 hours.

The change in airway responsiveness to methacholine will be determined as a dose shift in methacholine PD20 from baseline to each of the three timepoints

干预措施: Fluticasone furoate (Drug)

Matching Placebo

Placebo Comparator

Daily inhalation of inactive placebo comparator for 7 days Response to methacholine induced bronchoconstriction will be assessed on Day 1 before first inhalation of study treatment (baseline) and again at 24, 72 and 168 hours.

The change in airway responsiveness to methacholine will be determined as a dose shift in methacholine PD20 from baseline to each of the three timepoints

干预措施: Matching placebo (Other)

结局指标

主要结局

Methacholine provocation dose causing a 20% fall in FEV1 (PD20)

时间窗: 24 hours post dose, 72 hours post dose and 168 hours post dose

Change from baseline in airway response to inhaled methacholine following daily dosing with fluticasone furoate or placebo

次要结局

  • Fractional exhaled nitric oxide (FeNO)(168 hours)
  • Sputum eosinophils(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Don Cockcroft

Professor

University of Saskatchewan

研究点 (1)

Loading locations...

相似试验

Effect of Fluticasone Furoate on Methacholine... | 临床试验